Literature DB >> 21432455

Effect of eicosapentaenoic acid intake on the relationship between lnterleukin-6 and acute phase proteins in serum in youths.

N Sakamoto1, I Wakabayashi, S Yoshimoto, H Masui, K Sakamoto.   

Abstract

Twenty male volunteers 20-25 years old were examined to determine their serum concentrations of interleukin-6 (IL-6), acute phase proteins and lipids before, immediately after and one hour after a load of 90 watts for 20 minutes using a Monark ergometer, and the same parameters were reexamined after eicosapentaenoic acid (EPA) intake of 1.125 g/day for 2 weeks. By EPA intake, EPA level of the membranes of red blood cells increased significantly by 75.6% and docosahexanoic acid (DHA) by 53.8%. The IL-6 level increased significantly by 17% and C-reactive protein (CRP) by 11.7%, but fibrinogen (Fbg) decreased by 9.6%. After EPA intake, at one hour after the load, the change rate of IL-6 decreased to that of before EPA. The change rate of α(1)-acid glycoprotein ( α(1)-AGP) increased in the group in which IL-6 was unchanged and did so significantly in the group in which it increased, but tended to increase in the group in which it decreased. Thus the change rate of sialic acids (SA) increased significantly in both the IL-6 unchanged and increased groups. It is suggested that EPA activated IL-6, which was related to the increase of α(1)-AGP as an activator of immunity. The change rate of sialic acid (SA) as an index of acute phase protiens was correlated significantly and positively with that of total cholesterol and HDL-cholesterol.

Entities:  

Keywords:  Acute phase protein; Eicosapentaenoic acid; Interleukin-6; Physical exercise; Total-cholesterol

Year:  1997        PMID: 21432455      PMCID: PMC2723436          DOI: 10.1007/BF02931967

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  15 in total

1.  Cytokine immunoreactivity in plasma does not change after moderate endurance exercise.

Authors:  J A Smith; R D Telford; M S Baker; A J Hapel; M J Weidemann
Journal:  J Appl Physiol (1985)       Date:  1992-10

2.  Effect of oral n-3 fatty acid supplementation on the immune response of young and older women.

Authors:  S N Meydani; S Endres; M M Woods; B R Goldin; C Soo; A Morrill-Labrode; C A Dinarello; S L Gorbach
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

3.  Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells.

Authors:  J Gauldie; C Richards; D Harnish; P Lansdorp; H Baumann
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  [Evaluation of the correlation between serum sialic acid and various serum specific proteins].

Authors:  A Kosaka; H Matsumoto; M Ohori
Journal:  Rinsho Byori       Date:  1988-06

Review 5.  [I. Principles and applications of immunoassay: nephelometry related analysis].

Authors:  I Sakurabayashi; T Kawai
Journal:  Rinsho Byori       Date:  1983-02

Review 6.  The phenomenon of the acute phase response.

Authors:  I Kushner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency.

Authors:  A N Orekhov; V V Tertov; D N Mukhin
Journal:  Atherosclerosis       Date:  1991-02       Impact factor: 5.162

8.  Systemic production of interleukin-6 following acute inflammation.

Authors:  H Ohzato; M Monden; K Yoshizaki; A Ogata; N Nishimoto; M Gotoh; T Kishimoto; T Mori
Journal:  Biochem Biophys Res Commun       Date:  1993-12-30       Impact factor: 3.575

9.  Elevated plasma interleukin-6 levels in patients with acute myocardial infarction.

Authors:  Y Miyao; H Yasue; H Ogawa; I Misumi; T Masuda; T Sakamoto; E Morita
Journal:  Am Heart J       Date:  1993-12       Impact factor: 4.749

10.  Serum sialic acid concentration and cardiovascular mortality.

Authors:  G Lindberg; G A Eklund; B Gullberg; L Råstam
Journal:  BMJ       Date:  1991-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.